AVI BioPharma

AVI BioPharma

AVI BioPharma Inc. NASDAQAVII is a medical research and drug development company with corporate offices and research facility in Bothell, Washington, United States. Incorporated in 1980, the company maintains some laboratory capability in Corvallis, Oregon. As of 2008, the company has 170 issued medical patents, and over 150 patents pending.[1]

Contents

History

AVI BioPharma opened their own production laboratory in Corvallis, Oregon, in February 2002.[2] The company made headlines in 2003 when it announced work on treatments for SARS and the West Nile Virus.[2][3] In July 2009, the company announced they would move their headquarters from Portland, Oregon, north to Bothell, Washington, near Seattle.[4] At that time the company led by president and CEO Leslie Hudson had 83 employees and quarterly revenues of $3.2 million.[4] AVI had yet to turn a profit nor developed any commercial products as of July 2009.[4] The company lost $19.7 million in the second quarter of 2009,[5] and then won a $11.5 million contract with the U.S. Department of Defense's Defense Threat Reduction Agency in October 2009.[6] The company had completed its move to Bothell by this time, but retained their Corvallis facility.[4][6]

Products

Its primary products are Morpholino oligos (PMOs), conceived of by James Summerton and invented by Summerton with Dwight Weller, being developed under the name NeuGene Antisense. This form of antisense therapy uses a synthetic structural analog of RNA to bind to the messenger RNA produced by a known disease-causing gene strand and thus deactivate it.

Morpholinos have been tested for a wide range of applications including prevention of cardiac restenosis after angioplasty, treatment of coronary artery bypass grafts, treatment of polycystic kidney disease, and redirection of drug metabolism. Morpholinos have been used in preclinical studies to inhibit replication of West Nile Virus, SARS, Hepatitis C, dengue fever, Ebola and Calicivirus, all of which are single stranded RNA viruses. However, clinical studies have not demonstrated significant effects in humans and there are no approved drugs in this class.

In addition to development of Morpholinos as therapeutics, AVI has conducted six human trials for colorectal and pancreatic cancers using their cancer vaccine AVICINE.

References

  1. ^ AVI BioPharma official website
  2. ^ a b Moody, Robin J. (November 5, 2003). "AVI BioPharma's losses shrinking". Portland Business Journal. http://portland.bizjournals.com/portland/stories/2003/11/03/daily20.html. Retrieved 2009-10-24. 
  3. ^ Moody, Robin J. (June 12, 2003). "AVI BioPharma stock reaches new 52-week high". Portland Business Journal. http://portland.bizjournals.com/portland/stories/2003/06/09/daily40.html. Retrieved 2009-10-24. 
  4. ^ a b c d DiMesio, Robbie (July 30, 2009). "AVI BioPharma moving HQ out of Oregon". The Oregonian. http://www.oregonlive.com/business/index.ssf/2009/07/avi_biopharma_moving_hq_out_of.html. Retrieved 2009-10-24. 
  5. ^ "AVI BioPharma loses $19.7M in Q2". Portland Business Journal. August 10, 2009. http://portland.bizjournals.com/portland/stories/2009/08/10/daily2.html. Retrieved 2009-10-24. 
  6. ^ a b "AVI BioPharma gets $11.5M military contract". Portland Business Journal. October 5, 2009. http://portland.bizjournals.com/portland/stories/2009/10/05/daily1.html. Retrieved 2009-10-24. 

External links

Factory 1b.svg Companies portal

Wikimedia Foundation. 2010.

Игры ⚽ Нужно решить контрольную?

Look at other dictionaries:

  • Morpholino — Segment of a Morpholino RNA heteroduplex, 8 mer shown En biologie moléculaire, un morpholino est un type de molécule utilisé pour modifier l expression génétique. La technologie des oligonucléotides morpholinos est une technologie antisens… …   Wikipédia en Français

  • Morpholinos — Morpholino Segment of a Morpholino RNA heteroduplex, 8 mer shown En biologie moléculaire, un morpholino est un type de molécule utilisé pour modifier l expression génétique. La technologie des oligonucléotides morpholinos est une technologie… …   Wikipédia en Français

  • Phosphorodiamidate morpholino oligo — Morpholino Segment of a Morpholino RNA heteroduplex, 8 mer shown En biologie moléculaire, un morpholino est un type de molécule utilisé pour modifier l expression génétique. La technologie des oligonucléotides morpholinos est une technologie… …   Wikipédia en Français

  • Nuvelo — Inc. was a biopharmaceutical company engaged in the discovery, development and commercialization of drugs for acute cardiovascular disease, cancer and other debilitating medical conditions. On January 27, 2009, the company was acquired by ARCA… …   Wikipedia

  • Morpholino — Segment of a Morpholino RNA heteroduplex, 8 mer shown In molecular biology, a Morpholino is a molecule in a particular structural family that is used to modify gene expression. Morpholino oligomers (oligos) are an antisense technology used to… …   Wikipedia

  • AVICINE — was developed by AVI BioPharma Inc. It is a cancer vaccine which was created to causean immune reaction to the tumor associated antigen, human chorionic gonadotropin (hCG).This vaccine will be designed to work by actively stimulating immunization …   Wikipedia

  • Liste von Multiple-Sklerose-Wirkstoffen in der Erprobung — Für die immunmodulierende Langzeittherapie der Multiplen Sklerose sind derzeit acht Medikamente im deutschen Sprachraum zugelassen: drei Beta Interferone, Glatirameracetat, Mitoxantron, Azathioprin, Natalizumab und Fingolimod. Darüber hinaus gibt …   Deutsch Wikipedia

  • Influenza research — involves investigating molecular virology, pathogenesis, host immune responses, genomics, and epidemiology regarding influenza. The main goal of research is to develop influenza countermeasures such as vaccines, therapies and diagnostic tools.The …   Wikipedia

  • Corvallis, Oregon —   City   Motto: Enhancing Community Livability …   Wikipedia

  • Johnson & Johnson — Not to be confused with S. C. Johnson Son. Johnson Johnson Type Public Traded as NYSE:  …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”